Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmarketing Clinical Study on AO-128

NCT02287402 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02287402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02287402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmarketing Clinical Study on AO-128
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
November 30, 2012
Enrollment
197 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

impaired glucose tolerance (igt)